Vunakizumab Antibody
Vunakizumab is a humanized IgGκ monoclonal antibody targeting IL-17A. It is applied in research on psoriatic arthritis and, when complexed with IL-22, in studies of influenza-induced lung immune injury, facilitating both in vitro and in vivo experimental investigations.
Product Specifications
Product Name Alternative
IL Receptor, ILReceptor, IL-17A, Anti-Human IL17A Recombinant Antibody
Target
IL Receptor, Interleukin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.2 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.38 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
46409116 3x 1.0 µg
Tcp1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details